This impact is underscored by preclinical studies in Parkinson’s, Alzheimer’s and other CNS disease where FGF21 promotes neuroprotection and mitigates neurodegeneration through effects on different cell populations which crossover to ALS [75–81]. This evidence concerns the gene FGF21 and amyotrophic lateral sclerosis.